Document is current

Chapter History

First Online: 2 June 2022

Conflict of Interest Statement

: The author has no conflicts to declare.

: The author acknowledges research grants from the Jain Foundation Inc., pilot funding from AR3T (NIH P2C HD086843), R03HD091648 from the NIH, and FRAP and startup funds from Wayne State University, Detroit, MI, USA. The author acknowledges Visiting Scholar Awards from the Jain Foundation, Inc. and AR3T, through which he received training in methods to isolate and culture myogenic and other mononucleated cells from skeletal muscle tissue, at the laboratories of Dr. Amy J. Wagers (Joslin Diabetes Center, Harvard Medical School, Boston, MA) and Dr. Thomas A. Rando (Veterans Affairs Medical Center, Stanford Medicine, Palo Alto, CA), respectively. The author also expresses his gratitude to individuals with MDs and their caregivers, who have through their activism contributed to the vast body of knowledge on MDs. The author acknowledges Renuka Roche, PhD, OTR/L (Associate Professor, Occupational Therapy Program, Eastern Michigan University, Ypsilanti, MI, USA) for reading this chapter and providing scholarly input. The author acknowledges Mr. Senthil Kuppuswamy (Clinical Lead Occupational Therapist, Manchester University NHS Foundation Trust, Manchester, England, UK), and Sivaramkumar Shanmugam, PhD (Senior Lecturer in Physiotherapy, Glasgow Caledonian University, Glasgow, Scotland, UK), for insights shared on continuous quality improvement. The author expresses his sincere thanks to Antoine de Morrée, PhD, for sharing his expertise on culturing myogenic cells.